Personalized cell therapy (Adaptive Biotechnologies)

N/A

Report date: 2024/02/27 11:49:08

Base Information

Drug NamePersonalized cell therapy (Adaptive Biotechnologies)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research CenterAdaptive Biotechnologies Corp
China Registration ClassN/A

Develop Information

Active CompaniesAdaptive Biotechnologies Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A